RBM44
gene geneOn this page
Also known as FLJ40411
Summary
RBM44 (RNA binding motif protein 44, HGNC:24756) is a protein-coding gene on chromosome 2q37.3, encoding RNA-binding protein 44 (Q6ZP01). Component of intercellular bridges during meiosis.
Predicted to enable protein homodimerization activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to be located in cytoplasm and intercellular bridge. Predicted to be part of catalytic step 2 spliceosome.
Source: NCBI Gene 375316 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 144 total
- MANE Select transcript:
NM_001080504
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24756 |
| Approved symbol | RBM44 |
| Name | RNA binding motif protein 44 |
| Location | 2q37.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40411 |
| Ensembl gene | ENSG00000177483 |
| Ensembl biotype | protein_coding |
| OMIM | 621038 |
| Entrez | 375316 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000316997, ENST00000409864, ENST00000444524, ENST00000480583, ENST00000491996
RefSeq mRNA: 1 — MANE Select: NM_001080504
NM_001080504
CCDS: CCDS46554
Canonical transcript exons
ENST00000316997 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001417919 | 237798779 | 237798861 |
| ENSE00001547537 | 237821071 | 237821254 |
| ENSE00001553242 | 237820175 | 237820351 |
| ENSE00001731498 | 237841839 | 237842805 |
| ENSE00003515352 | 237816993 | 237818596 |
| ENSE00003522973 | 237834278 | 237834423 |
| ENSE00003533278 | 237827433 | 237827503 |
| ENSE00003566579 | 237823440 | 237823554 |
| ENSE00003580848 | 237833997 | 237834142 |
| ENSE00003611478 | 237821743 | 237821827 |
| ENSE00003626473 | 237821346 | 237821368 |
| ENSE00003626621 | 237824291 | 237824419 |
| ENSE00003633111 | 237813592 | 237813682 |
| ENSE00003680675 | 237818901 | 237818959 |
| ENSE00003681240 | 237829217 | 237829502 |
| ENSE00003690865 | 237827250 | 237827329 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 86.90.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0906 / max 57.2878, expressed in 14 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 26299 | 0.0764 | 14 |
| 26298 | 0.0142 | 3 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.90 | gold quality |
| right testis | UBERON:0004534 | 82.22 | gold quality |
| testis | UBERON:0000473 | 81.39 | gold quality |
| left testis | UBERON:0004533 | 80.25 | gold quality |
| thymus | UBERON:0002370 | 72.22 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.98 | gold quality |
| monocyte | CL:0000576 | 66.94 | gold quality |
| calcaneal tendon | UBERON:0003701 | 66.71 | gold quality |
| bone marrow | UBERON:0002371 | 65.94 | gold quality |
| leukocyte | CL:0000738 | 65.76 | gold quality |
| quadriceps femoris | UBERON:0001377 | 65.49 | gold quality |
| cerebellar vermis | UBERON:0004720 | 64.61 | gold quality |
| cortical plate | UBERON:0005343 | 64.31 | gold quality |
| tibial artery | UBERON:0007610 | 63.91 | gold quality |
| popliteal artery | UBERON:0002250 | 63.88 | gold quality |
| thoracic aorta | UBERON:0001515 | 63.82 | gold quality |
| ascending aorta | UBERON:0001496 | 63.76 | gold quality |
| mucosa of stomach | UBERON:0001199 | 63.61 | gold quality |
| bone marrow cell | CL:0002092 | 63.38 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 63.35 | gold quality |
| right coronary artery | UBERON:0001625 | 63.12 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 62.96 | gold quality |
| metanephros cortex | UBERON:0010533 | 62.39 | gold quality |
| right lung | UBERON:0002167 | 61.93 | gold quality |
| adipose tissue | UBERON:0001013 | 61.56 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 61.16 | gold quality |
| left coronary artery | UBERON:0001626 | 60.93 | gold quality |
| myometrium | UBERON:0001296 | 60.61 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 60.14 | gold quality |
| omental fat pad | UBERON:0010414 | 59.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.11 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
81 targeting RBM44, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
| HSA-MIR-302D-3P | 99.89 | 71.25 | 1777 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-373-3P | 99.84 | 70.68 | 1668 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rbm44 | ENSMUSG00000070732 |
| rattus_norvegicus | Rbm44 | ENSRNOG00000024878 |
Protein
Protein identifiers
RNA-binding protein 44 — Q6ZP01 (reviewed: Q6ZP01)
Alternative names: RNA-binding motif protein 44
All UniProt accessions (1): Q6ZP01
UniProt curated annotations — full annotation on UniProt →
Function. Component of intercellular bridges during meiosis. Intercellular bridges are evolutionarily conserved structures that connect differentiating germ cells. Not required for fertility.
Subunit / interactions. Homodimer. Interacts with TEX14.
Subcellular location. Cytoplasm.
RefSeq proteins (1): NP_001073973* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000504 | RRM_dom | Domain |
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
| IPR056870 | TTC3/DZIP3/RBM44-like_helical | Domain |
Pfam: PF00076, PF24905
UniProt features (18 total): region of interest 5, compositionally biased region 4, modified residue 4, sequence variant 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZP01-F1 | 45.58 | 0.06 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 388, 391, 546, 726
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 64 (showing top):
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_RNA_SPLICING, GOCC_CATALYTIC_STEP_2_SPLICEOSOME, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_INTERCELLULAR_BRIDGE, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY, GOMF_MRNA_BINDING, GOMF_MRNA_3_UTR_BINDING, GOBP_MRNA_PROCESSING, KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES, GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN, GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP, HMGA1_TARGET_GENES
GO Biological Process (1): mRNA splicing, via spliceosome (GO:0000398)
GO Molecular Function (4): mRNA 3’-UTR binding (GO:0003730), protein homodimerization activity (GO:0042803), nucleic acid binding (GO:0003676), RNA binding (GO:0003723)
GO Cellular Component (3): cytoplasm (GO:0005737), intercellular bridge (GO:0045171), catalytic step 2 spliceosome (GO:0071013)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 |
| mRNA processing | 1 |
| mRNA binding | 1 |
| identical protein binding | 1 |
| protein dimerization activity | 1 |
| binding | 1 |
| nucleic acid binding | 1 |
| intracellular anatomical structure | 1 |
| Prp19 complex | 1 |
| spliceosomal complex | 1 |
| U5 snRNP | 1 |
| catalytic complex | 1 |
Protein interactions and networks
STRING
378 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RBM44 | TEX14 | Q8IWB6 | 757 |
| RBM44 | CEP55 | Q53EZ4 | 553 |
| RBM44 | SRFBP1 | Q8NEF9 | 520 |
| RBM44 | ASMTL | O95671 | 518 |
| RBM44 | C6orf52 | Q5T4I8 | 507 |
| RBM44 | RAMP1 | O60894 | 493 |
| RBM44 | TSN | Q15631 | 462 |
| RBM44 | NANOS2 | P60321 | 460 |
| RBM44 | FAM181A | Q8N9Y4 | 443 |
| RBM44 | CCDC116 | Q8IYX3 | 437 |
| RBM44 | NANOS3 | P60323 | 437 |
| RBM44 | DAZL | Q92904 | 433 |
| RBM44 | LRRFIP1 | Q32MZ4 | 433 |
| RBM44 | KIAA1210 | Q9ULL0 | 402 |
| RBM44 | TIPE2 | Q6P589 | 383 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RBM44 | NPM1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| M | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): RBM44 (Proximity Label-MS), RBM44 (Protein-RNA), RBM44 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WRU1, A0JNH1, A2RUB1, A6QNQ6, B0S6S9, B1WC58, D3Z987, D3ZJ47, E1BC15, O60673, P28358, P28359, P56716, P70347, Q0P5X5, Q0VAV2, Q0VBV7, Q15468, Q2M2Z5, Q3UXL4, Q3V089, Q49A88, Q569L8, Q5BQN8, Q5CZC0, Q5QGS0, Q5T1N1, Q5VWN6, Q60988, Q61493, Q62924, Q6ZP01, Q6ZU52, Q6ZVD7, Q80U59, Q80WQ8, Q86WS4, Q86YC2, Q8CB14, Q8IUR6
Diamond homologs: D3Z987, E1BC15, Q3V089, Q6ZP01
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
144 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 123 |
| Likely benign | 16 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2576 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:237813590:A:AG | acceptor_gain | 1.0000 |
| 2:237813591:G:GG | acceptor_gain | 1.0000 |
| 2:237813591:GATT:G | acceptor_gain | 1.0000 |
| 2:237820287:A:G | donor_gain | 1.0000 |
| 2:237820338:G:GT | donor_gain | 1.0000 |
| 2:237820338:G:T | donor_gain | 1.0000 |
| 2:237820342:GAT:G | donor_gain | 1.0000 |
| 2:237821828:G:GG | donor_gain | 1.0000 |
| 2:237823431:A:AG | acceptor_gain | 1.0000 |
| 2:237823551:AAAG:A | donor_loss | 1.0000 |
| 2:237823552:AAGG:A | donor_loss | 1.0000 |
| 2:237823553:AGGTT:A | donor_loss | 1.0000 |
| 2:237823555:G:GC | donor_loss | 1.0000 |
| 2:237824416:GGAG:G | donor_gain | 1.0000 |
| 2:237824417:GAGG:G | donor_gain | 1.0000 |
| 2:237833993:TTAG:T | acceptor_loss | 1.0000 |
| 2:237833995:A:AG | acceptor_gain | 1.0000 |
| 2:237833995:AG:A | acceptor_gain | 1.0000 |
| 2:237833996:G:A | acceptor_gain | 1.0000 |
| 2:237833996:G:GG | acceptor_gain | 1.0000 |
| 2:237833996:GGGT:G | acceptor_gain | 1.0000 |
| 2:237834139:GCAG:G | donor_gain | 1.0000 |
| 2:237834140:CAGGT:C | donor_loss | 1.0000 |
| 2:237834141:AGGTA:A | donor_loss | 1.0000 |
| 2:237834143:G:C | donor_loss | 1.0000 |
| 2:237834144:T:A | donor_loss | 1.0000 |
| 2:237834273:CATA:C | acceptor_loss | 1.0000 |
| 2:237834274:ATAG:A | acceptor_loss | 1.0000 |
| 2:237834275:T:G | acceptor_gain | 1.0000 |
| 2:237834275:TA:T | acceptor_loss | 1.0000 |
AlphaMissense
7015 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:237829261:C:A | A883D | 0.986 |
| 2:237827440:T:C | L847S | 0.985 |
| 2:237827452:T:C | F851S | 0.984 |
| 2:237827451:T:C | F851L | 0.976 |
| 2:237827453:C:A | F851L | 0.976 |
| 2:237827453:C:G | F851L | 0.976 |
| 2:237834090:A:C | S995R | 0.976 |
| 2:237834092:C:A | S995R | 0.976 |
| 2:237834092:C:G | S995R | 0.976 |
| 2:237834115:T:C | L1003P | 0.976 |
| 2:237829222:C:A | A870E | 0.974 |
| 2:237834294:G:C | A1018P | 0.973 |
| 2:237827301:T:A | V835D | 0.971 |
| 2:237834298:T:C | L1019P | 0.969 |
| 2:237818339:T:C | F475L | 0.958 |
| 2:237818341:T:A | F475L | 0.958 |
| 2:237818341:T:G | F475L | 0.958 |
| 2:237829221:G:C | A870P | 0.958 |
| 2:237820254:G:C | A607P | 0.956 |
| 2:237834298:T:A | L1019H | 0.956 |
| 2:237829228:T:A | L872H | 0.954 |
| 2:237820267:T:C | L611P | 0.953 |
| 2:237829228:T:C | L872P | 0.949 |
| 2:237817487:A:C | S191R | 0.948 |
| 2:237817489:T:A | S191R | 0.948 |
| 2:237817489:T:G | S191R | 0.948 |
| 2:237834115:T:A | L1003Q | 0.947 |
| 2:237827310:T:A | L838H | 0.946 |
| 2:237827461:A:C | Y854S | 0.945 |
| 2:237829309:T:A | V899E | 0.943 |
dbSNP variants (sampled 300 via entrez): RS1000020053 (2:237803485 A>T), RS1000046445 (2:237823772 ATTC>A), RS1000122494 (2:237840064 C>A,G,T), RS1000122606 (2:237833594 A>G), RS1000136905 (2:237796972 T>C), RS1000211012 (2:237837121 ACTC>A), RS1000313562 (2:237836737 G>A), RS1000426723 (2:237816368 C>T), RS1000445132 (2:237829788 A>G), RS1000473507 (2:237837446 A>T), RS1000567773 (2:237798728 G>A,C), RS1000568403 (2:237811803 C>A), RS1000635 (2:237826472 C>T), RS1000636 (2:237826693 G>A,T), RS1000774895 (2:237831410 A>G)
Disease associations
OMIM: gene MIM:621038 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004523_9 | Resting metabolic rate | 8.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008004 | resting metabolic rate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | increases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| bisphenol S | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Asbestos, Serpentine | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.